BioSpace News Archive

Qualivis, a national provider of healthcare workforce solutions, endorsed by 15 hospital associations throughout the United States, has joined forces with HAPevolve to bring its vendor-neutral service model to the state of Pennsylvania.

Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today reported financial results for the second quarter ended June 30, 2019 and provided key business updates.

DON Recovery Services (DRS) has chosen to implement the MedicsCloud Addiction Medicine Clinical and Financial Suite from Advanced Data Systems (ADS) for electronic health records (EHR), Patient Workflow Design, and Billing Technology.

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company which was granted FDA clearance for its Intravaginal Culture System, INVOcell®, today announced financial results for the second quarter of 2019, ended June 30, 2019.

The Alliance to Prevent Legionnaires’ Disease issued the following statement in response to the release of the Management of Legionella in Water Systems report from the National Academies of Sciences, Engineering, and Medicine

CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended June 30, 2019.

Huntington Hospital announced that local philanthropists, Terri and Jerry Kohl have made a gift of $7 million to support the expansion of its new Huntington Heart and Vascular Center.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) today announced its financial results for the first quarter ended June 30, 2019

AgeX Therapeutics, Inc., a biotechnology company focused on the development of therapeutics for human aging, reported financial and operating results for the second quarter ended June 30, 2019.

Deciphera Pharmaceuticals, Inc. announced the pricing of its previously announced registered underwritten public offering of 10,810,810 shares of its common stock at a price to the public of $37.00 per share.